DOI QR코드

DOI QR Code

Hemorrhagic Moyamoya Disease : A Recent Update

  • Received : 2018.05.01
  • Accepted : 2018.05.09
  • Published : 2019.03.01

Abstract

Moyamoya disease (MMD) is a progressive cerebrovascular disease with unknown etiology, characterized by bilateral steno-occlusive changes at the terminal portion of the internal carotid artery and an abnormal vascular network formation at the base of the brain. MMD has an intrinsic nature to convert the vascular supply for the brain from internal carotid (IC) system to the external carotid (EC) system, as indicated by Suzuki's angiographic staging. Insufficiency of this 'IC-EC conversion system' could result not only in cerebral ischemia, but also in intracranial hemorrhage from inadequate collateral anastomosis, both of which represent the clinical manifestation of MMD. Surgical revascularization prevents cerebral ischemic attack by improving cerebral blood flow, and recent evidence further suggests that extracranial-intracranial bypass could powerfully reduce the risk of re-bleeding in MMD patients with posterior hemorrhage, who were known to have extremely high re-bleeding risk. Although the exact mechanism underlying the hemorrhagic presentation in MMD is undetermined, most recent angiographic analysis revealed the characteristic angio-architecture related to high re-bleeding risk, such as the extension and dilatation of choroidal collaterals and posterior cerebral artery involvement. We sought to update the current management strategy for hemorrhagic MMD, including the outcome of surgical revascularization for hemorrhagic MMD in our institute. Further investigations will clarify the optimal surgical strategy to prevent hemorrhagic manifestation in patients with MMD.

Keywords

References

  1. Fujimura M, Funaki T, Houkin K, Takahashi JC, Kuroda S, Tomata Y, et al. : Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan adult moyamoya trial. J Neurosurg, 2018 [Epub ahead of print]
  2. Fujimura M, Inoue T, Shimizu H, Saito A, Mugikura S, Tominaga T : Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. Cerebrovasc Dis 33 : 436-445, 2012 https://doi.org/10.1159/000336765
  3. Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T : Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67 : 273-282, 2007 https://doi.org/10.1016/j.surneu.2006.07.017
  4. Fujimura M, Kaneta T, Shimizu H, Tominaga T : Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease. Neurosurg Rev 32 : 245-249, 2009 https://doi.org/10.1007/s10143-009-0184-6
  5. Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T : Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 71 : 442-447, 2009 https://doi.org/10.1016/j.surneu.2008.02.031
  6. Fujimura M, Niizuma K, Inoue T, Sato K, Endo H, Shimizu H, et al. : Minocycline prevents focal neurologic deterioration due to cerebral hyperperfusion after extracranial-intracranial bypass for moyamoya disease. Neurosurgery 74 : 163-170; discussion 170, 2014 https://doi.org/10.1227/NEU.0000000000000238
  7. Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T : Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using Nisopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography. Neurosurgery 68 : 957-964, 2011 https://doi.org/10.1227/NEU.0b013e318208f1da
  8. Fujimura M, Shimizu H, Mugikura S, Tominaga T : Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 71 : 223-227, 2009 https://doi.org/10.1016/j.surneu.2007.07.077
  9. Fujimura M, Sonobe S, Nishijima Y, Niizuma K, Sakata H, Kure S, et al. : Genetics and biomarkers of moyamoya disease: significance of RNF213 as a susceptibility gene. J Stroke 16 : 65-72, 2014 https://doi.org/10.5853/jos.2014.16.2.65
  10. Fujimura M, Tominaga T : Current status of revascularization surgery for moyamoya disease: special consideration for its 'internal carotidexternal carotid (IC-EC) conversion' as the physiological reorganization system. Tohoku J Exp Med 236 : 45-53, 2015 https://doi.org/10.1620/tjem.236.45
  11. Fujimura M, Tominaga T : Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres. Neurol Med Chir (Tokyo) 52 : 327-332, 2012 https://doi.org/10.2176/nmc.52.327
  12. Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T : Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 72 : 476-480, 2009 https://doi.org/10.1016/j.surneu.2008.10.009
  13. Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. : Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan adult moyamoya trial. J Neurosurg 128 : 777-784, 2018 https://doi.org/10.3171/2016.11.JNS161650
  14. Funaki T, Takahashi JC, Houkin K, Kuroda S, Takeuchi S, Fujimura M, et al. : High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan adult moyamoya trial. J Neurosurg, 2018 [Epub ahead of print]
  15. Funaki T, Takahashi JC, Yoshida K, Takagi Y, Fushimi Y, Kikuchi T, et al. : Periventricular anastomosis in moyamoya disease: detecting fragile collateral vessels with MR angiography. J Neurosurg 124 : 1766-1772, 2016 https://doi.org/10.3171/2015.6.JNS15845
  16. Hayashi K, Horie N, Izumo T, Nagata I : A nationwide survey on unilateral moyamoya disease in Japan. Clin Neurol Neurosurg 124 : 1-5, 2014 https://doi.org/10.1016/j.clineuro.2014.06.010
  17. Hayashi T, Shirane R, Fujimura M, Tominaga T : Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion. J Neurosurg Pediatr 6 : 73-81, 2010 https://doi.org/10.3171/2010.4.PEDS09478
  18. Houkin K, Ishikawa T, Yoshimoto T, Abe H : Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99 Suppl 2 : S142-S145, 1997
  19. Hwang JW, Yang HM, Lee H, Lee HK, Jeon YT, Kim JE, et al. : Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease. Br J Anaesth 110 : 773-779, 2013 https://doi.org/10.1093/bja/aes470
  20. Irikura K, Miyasaka Y, Kurata A, Tanaka R, Fujii K, Yada K, et al. : A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 138 : 1282-1286, 1996 https://doi.org/10.1007/BF01411056
  21. Kaku Y, Morioka M, Ohmori Y, Kawano T, Kai Y, Fukuoka H, et al. : Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis? Acta Neurochir (Wien) 154 : 2151-2157, 2012 https://doi.org/10.1007/s00701-012-1472-4
  22. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. : A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 56 : 34-40, 2011 https://doi.org/10.1038/jhg.2010.132
  23. Kang HS, Kim JH, Phi JH, Kim YY, Kim JE, Wang KC, et al. : Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 81 : 673-678, 2010 https://doi.org/10.1136/jnnp.2009.191817
  24. Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK : Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis 25 : 580-586, 2008 https://doi.org/10.1159/000132205
  25. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y, Research Committee on Moyamoya Disease in Japan : Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 38 : 1430-1435, 2007 https://doi.org/10.1161/STROKEAHA.106.478297
  26. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y : Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36 : 2148-2153, 2005 https://doi.org/10.1161/01.STR.0000182256.32489.99
  27. Kuroda S, Kashiwazaki D, Akioka N, Koh M, Hori E, Nishikata M, et al. : Specific shrinkage of carotid forks in moyamoya disease: a novel key finding for diagnosis. Neurol Med Chir (Tokyo) 55 : 796-804, 2015 https://doi.org/10.2176/nmc.oa.2015-0044
  28. Miyamoto S, Yoshimoto T, Hashimoto N, Okada Y, Tsuji I, Tominaga T, et al. : Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the japan adult moyamoya trial. Stroke 45 : 1415-1421, 2014 https://doi.org/10.1161/STROKEAHA.113.004386
  29. Morioka M, Hamada J, Kawano T, Todaka T, Yano S, Kai Y, et al. : Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34 : 90-95, 2003 https://doi.org/10.1161/01.STR.0000047120.67507.0D
  30. Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases : Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52 : 245-266, 2012 https://doi.org/10.2176/nmc.52.245
  31. Ryoo S, Cha J, Kim SJ, Choi JW, Ki CS, Kim KH, et al. : High-resolution magnetic resonance wall imaging findings of moyamoya disease. Stroke 45 : 2457-2460, 2014 https://doi.org/10.1161/STROKEAHA.114.004761
  32. Sakata H, Fujimura M, Mugikura S, Sato K, Tominaga T : Local vasogenic edema without cerebral hyperperfusion after direct revascularization surgery for moyamoya disease. J Stroke Cerebrovasc Dis 24 : e179-e184, 2015 https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.050
  33. Suzuki J, Takaku A : Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20 : 288-299, 1969 https://doi.org/10.1001/archneur.1969.00480090076012
  34. Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, et al. : Significance of the hemorrhagic site for recurrent bleeding: prespecified analysis in the Japan adult moyamoya trial. Stroke 47 : 37-43, 2016 https://doi.org/10.1161/STROKEAHA.115.010819
  35. Tashiro R, Fujimura M, Mugikura S, Niizuma K, Endo H, Endo T, et al. : Paradoxical association of symptomatic local vasogenic edema with global cerebral hypoperfusion after direct revascularization surgery for adult moyamoya disease. J Stroke Cerebrlvasc Dis, 2018 [Epub ahead of print]
  36. Tominaga T, Suzuki N, Miyamoto S, Koizumi A, Kuroda S, Takahashi JC, et al. : Recommendations for the management of moyamoya disease: a statement from research committee on spontaneous occlusion of the circle of Willis (moyamoya disease) [2nd Edition]. Surg Cereb Stroke 46 : 1-24, 2018 https://doi.org/10.2335/scs.46.1
  37. Tu XK, Fujimura M, Rashad S, Mugikura S, Sakata H, Niizuma K, et al. : Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'. Neurosurg Rev 40 : 507-512, 2017 https://doi.org/10.1007/s10143-017-0845-9
  38. Uchino H, Kuroda S, Hirata K, Shiga T, Houkin K, Tamaki N : Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study. Stroke 43 : 2610-2616, 2012 https://doi.org/10.1161/STROKEAHA.112.654723
  39. Uchino H, Nakayama N, Kazumata K, Kuroda S, Houkin K : Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study. Stroke 47 : 1930-1932, 2016 https://doi.org/10.1161/STROKEAHA.116.013304
  40. Yuan M, Liu ZQ, Wang ZQ, Li B, Xu LJ, Xiao XL : High-resolution MR imaging of the arterial wall in moyamoya disease. Neurosci Lett 584 : 77-82, 2015 https://doi.org/10.1016/j.neulet.2014.10.021

Cited by

  1. Moyamoya Disease : Modern Diagnostic Criteria and Current Status of Revascularization Surgery vol.28, pp.12, 2019, https://doi.org/10.7887/jcns.28.789
  2. Neuro-endoscopic management of hemorrhagic moyamoya disease in the acute stage: single institute experience vol.41, pp.12, 2019, https://doi.org/10.1080/01616412.2019.1674006
  3. Predicting Decreased Activities of Daily Living in Patients with Moyamoya Disease after Revascularization: Development and Assessment of a New Predictive Nomogram vol.2021, 2019, https://doi.org/10.1155/2021/6624245
  4. Delayed Anastomotic Occlusion after Direct Revascularization in Adult Hemorrhagic Moyamoya Disease vol.11, pp.5, 2021, https://doi.org/10.3390/brainsci11050536